COSMO Pharmaceuticals SA (0RGI) — Financial Flexibility Index
COSMO Pharmaceuticals SA (0RGI) has a Financial Flexibility Index of 0.02x as of June 2025. Free cash flow of £3.52 Million (operating CF £900.00K minus capex £2.62 Million) represents 0% of total liabilities (£143.35 Million). Check COSMO Pharmaceuticals SA (0RGI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
COSMO Pharmaceuticals SA Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for COSMO Pharmaceuticals SA across 21 annual periods. See COSMO Pharmaceuticals SA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for COSMO Pharmaceuticals SA (2004–2024)
Year-by-year free cash flow to debt coverage for COSMO Pharmaceuticals SA. For the full company profile including market capitalisation, see COSMO Pharmaceuticals SA stock valuation.
| Year | Flexibility Index | Free Cash Flow (GBP) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | £168.06 Million | £162.41 Million | £141.68 Million | ▲ +446.8% |
| 2023 | 0.22x | £27.10 Million | £22.71 Million | £124.94 Million | ▲ +71.7% |
| 2022 | 0.13x | £37.37 Million | £32.89 Million | £295.80 Million | ▲ +75.2% |
| 2021 | 0.07x | £21.11 Million | £12.61 Million | £292.88 Million | ▼ -32.9% |
| 2020 | 0.11x | £21.07 Million | £12.98 Million | £196.04 Million | ▲ +1441.2% |
| 2019 | -0.01x | £-1.53 Million | £-18.85 Million | £191.43 Million | ▼ -194.5% |
| 2018 | 0.00x | £-492.00K | £-10.16 Million | £180.83 Million | ▼ -100.6% |
| 2017 | 0.43x | £12.03 Million | £-10.01 Million | £27.86 Million | ▼ -73.1% |
| 2016 | 1.61x | £44.84 Million | £26.41 Million | £27.92 Million | ▲ +250.1% |
| 2015 | -1.07x | £-36.69 Million | £-39.23 Million | £34.30 Million | ▼ -213.8% |
| 2014 | 0.94x | £68.96 Million | £66.45 Million | £73.33 Million | ▲ +98.2% |
| 2013 | 0.47x | £10.84 Million | £8.11 Million | £22.85 Million | ▼ -50.4% |
| 2012 | 0.96x | £26.04 Million | £23.00 Million | £27.24 Million | ▼ -4.8% |
| 2011 | 1.00x | £14.66 Million | £11.29 Million | £14.60 Million | ▲ +120.9% |
| 2010 | 0.45x | £15.21 Million | £7.79 Million | £33.46 Million | ▼ -49.9% |
| 2009 | 0.91x | £10.60 Million | £3.88 Million | £11.67 Million | ▲ +285.1% |
| 2008 | -0.49x | £-7.13 Million | £-12.52 Million | £14.53 Million | ▼ -306.2% |
| 2007 | -0.12x | £-1.46 Million | £-2.52 Million | £12.08 Million | ▼ -115.6% |
| 2006 | 0.78x | £14.18 Million | £6.08 Million | £18.27 Million | ▲ +262.9% |
| 2005 | 0.21x | £5.90 Million | £1.70 Million | £27.58 Million | ▲ +92.6% |
| 2004 | 0.11x | £2.70 Million | £261.00K | £24.34 Million | — |